These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Demonstration of a role for growth hormone in glucose counterregulation. De Feo P, Perriello G, Torlone E, Ventura MM, Santeusanio F, Brunetti P, Gerich JE, Bolli GB. Am J Physiol; 1989 Jun; 256(6 Pt 1):E835-43. PubMed ID: 2567576 [Abstract] [Full Text] [Related]
7. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. Fanelli C, Calderone S, Epifano L, De Vincenzo A, Modarelli F, Pampanelli S, Perriello G, De Feo P, Brunetti P, Gerich JE. J Clin Invest; 1993 Oct; 92(4):1617-22. PubMed ID: 8408616 [Abstract] [Full Text] [Related]
8. Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans. Heller SR, Cryer PE. Am J Physiol; 1991 Jul; 261(1 Pt 1):E41-8. PubMed ID: 1858873 [Abstract] [Full Text] [Related]
9. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. Schwartz NS, Clutter WE, Shah SD, Cryer PE. J Clin Invest; 1987 Mar; 79(3):777-81. PubMed ID: 3546378 [Abstract] [Full Text] [Related]
13. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting. Boyle PJ, Shah SD, Cryer PE. Am J Physiol; 1989 May; 256(5 Pt 1):E651-61. PubMed ID: 2655471 [Abstract] [Full Text] [Related]
14. Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans. De Feo P, Perriello G, De Cosmo S, Ventura MM, Campbell PJ, Brunetti P, Gerich JE, Bolli GB. Diabetes; 1986 May; 35(5):563-9. PubMed ID: 2869997 [Abstract] [Full Text] [Related]
15. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus. Orskov L, Alberti KG, Mengel A, Møller N, Pedersen O, Rasmussen O, Seefeldt T, Schmitz O. Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058 [Abstract] [Full Text] [Related]
16. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon. Staten MA, Matthews DE, Cryer PE, Bier DM. Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829 [Abstract] [Full Text] [Related]
17. Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects. Tse TF, Clutter WE, Shah SD, Miller JP, Cryer PE. J Clin Invest; 1983 Jul; 72(1):270-7. PubMed ID: 6409929 [Abstract] [Full Text] [Related]
18. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L, Sherwin R, Hendler R, Felig P. J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [Abstract] [Full Text] [Related]
19. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise. Tuttle KR, Marker JC, Dalsky GP, Schwartz NS, Shah SD, Clutter WE, Holloszy JO, Cryer PE. Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952 [Abstract] [Full Text] [Related]
20. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA, Cryer PE, Gerich JE. J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413 [Abstract] [Full Text] [Related] Page: [Next] [New Search]